Whitehawk Therapeutics (WHWK) Cash from Financing Activities (2010 - 2025)
Whitehawk Therapeutics (WHWK) reported Cash from Financing Activities of $25000.0 for Q4 2025, down 52.83% year-over-year from $53000.0 in Q4 2024, and up 102.94% on a QoQ basis from -$850000.0 in Q2 2025.
Whitehawk Therapeutics (WHWK) has 12 years of Cash from Financing Activities data on file, last reported at $25000.0 in Q4 2025.
- Quarterly Cash from Financing Activities fell 52.83% year-over-year to $25000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$825000.0 (down 100.87% YoY) and the FY2025 annual result came in at $94.4 million, up 72496.92% from the prior year.
- Cash from Financing Activities advanced to $25000.0 in Q4 2025 per WHWK's latest filing, from -$850000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $141.7 million in Q3 2021 and bottomed at -$850000.0 in Q2 2025.
- The 5-year median for Cash from Financing Activities is $61639.5 (2021), against an average of $17.2 million.
- Peak annual rise in Cash from Financing Activities reached 952110.0% in 2025, while the deepest fall reached 1077.01% in 2025.
- Tracing WHWK's Cash from Financing Activities over 5 years: stood at $88000.0 in 2021, then plunged by 221.59% to -$107000.0 in 2022, then surged by 174.77% to $80000.0 in 2023, then tumbled by 33.75% to $53000.0 in 2024, then plunged by 52.83% to $25000.0 in 2025.
- Per Business Quant, the three latest WHWK Cash from Financing Activities figures stand at $25000.0 (Q4 2025), -$850000.0 (Q2 2025), and $95.2 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Jun 30, 2025 | -850,000.00 |
| Jun 30, 2025 | -850,000.00 |
| Mar 31, 2025 | 95.20 Mn |
| Mar 31, 2025 | 95.20 Mn |
| Dec 31, 2024 | 53,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | 313,000.00 |
| Jun 30, 2023 | 313,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | -107,000.00 |
| Dec 31, 2022 | -107,000.00 |
| Sep 30, 2022 | 72.52 Mn |
| Sep 30, 2022 | 72.52 Mn |
| Jun 30, 2022 | -87,000.00 |
| Jun 30, 2022 | -87,000.00 |
| Mar 31, 2022 | 298,000.00 |
| Mar 31, 2022 | 298,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 141.72 Mn |
| Sep 30, 2021 | 141.72 Mn |
| Jun 30, 2021 | -71,279.00 |
| Jun 30, 2021 | -71,279.00 |
| Mar 31, 2021 | 70,279.00 |
| Mar 31, 2021 | 70,279.00 |
| Dec 31, 2018 | 76.00 |
| Dec 31, 2018 | 76.00 |
| Sep 30, 2018 | 6.27 Mn |
| Sep 30, 2018 | 6.27 Mn |
| Jun 30, 2018 | 41.91 Mn |
| Jun 30, 2018 | 41.91 Mn |
| Mar 31, 2018 | 21,992.00 |
| Mar 31, 2018 | 21,992.00 |
| Dec 31, 2017 | 1.00 |
| Dec 31, 2017 | 1.00 |
| Jun 30, 2017 | 36,101.00 |
| Jun 30, 2017 | 36,101.00 |
| Mar 31, 2017 | 37.46 Mn |
| Mar 31, 2017 | 37.46 Mn |
| Dec 31, 2016 | 3.34 Mn |
| Dec 31, 2016 | 3.34 Mn |
| Sep 30, 2016 | 4.54 Mn |
| Sep 30, 2016 | 4.54 Mn |
| Dec 31, 2015 | 15,000.00 |
| Dec 31, 2015 | 15,000.00 |
| Mar 31, 2015 | 20,000.00 |
| Mar 31, 2015 | 20,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |